The Food and Drug Administration (FDA) has issued guidance to whiskey producers on how to comply with a new rule issued by the Federal Trade Commission (FTC).
The agency said it will be sending out a second batch of the new guidelines next week.
The FTC said it would be sending another batch of whiskey guidelines next month.
It will cover products with ingredients that are biocommatible and those that are not.
The FDA said that in the last decade, biocontent in whiskey has been declining at an annual rate of 1.3% per year, according to the agency.
The agency is recommending that companies label the products they are selling with the words “Biocompatibile.”
“While it is not a mandatory label, it should be part of a list of warning labels on products that are meant to be consumed by individuals with or without certain health conditions, such as cancer,” the FDA said.
Whiskey has been a popular product for decades.
It has been promoted as a healthy beverage and has been the target of a number of anti-alcohol campaigns.
But it has also been blamed for alcohol-related problems, including liver damage and death.
